Health state | Year | Resource | Resource utilization rate (per person) | Mean cost (95% CI), $ |
---|---|---|---|---|
Low-risk breast cancer | 1 | Surgery | 1.00 | 7312 (7111 to 7512) |
Genetic testing* | 0.51 | 2719 (2480 to 2957) | ||
Systemic therapy | 0.59 | 3008 (2085 to 3931) | ||
Radiotherapy | 0.51 | 4283 (3893 to 4667) | ||
End-of-life breast cancer care | NR | 0 | ||
2 | Surgery | NR | 85 (17 to 153) | |
Systemic therapy | 0.53 | 1577 (999 to 2156) | ||
Radiotherapy | 0 | 54 (−22 to 131) | ||
End-of-life breast cancer care | NR | 0 | ||
3 | Surgery | 0.06 | 40 (−16 to 96) | |
Systemic therapy | 0.48 | 450 (123 to 776) | ||
Radiotherapy | NR | 90 (−50 to 231) | ||
End-of-life breast cancer care | NR | 0 | ||
4 | Surgery | 0 | 213 (−206 to 634) | |
Systemic therapy | 0.50 | 241 (137 to 346) | ||
Radiotherapy | 0.01 | 120 (−50 to 288) | ||
End-of-life breast cancer care | NR | 214 (−106 to 634) | ||
5 | Surgery | 0 | 79 (−77 to 235) | |
Systemic therapy | 0.48 | 516 (−251 to 1285) | ||
Radiotherapy | 0 | 0 | ||
End-of-life breast cancer care | NR | 0 | ||
6–40 | Continue year 5 | |||
High-risk breast cancer | 1 | Surgery | 0.96 | 7881 (7547 to 8216) |
Systemic therapy | 0.98 | 19 664 (17 496 to 21 832) | ||
Radiotherapy | 0.79 | 9019 (8457 to 9581) | ||
End-of-life breast cancer care | NR | 274 (−106 to 655) | ||
2 | Surgery | 0.02 | 111 (10 to 213) | |
Systemic therapy | 0.83 | 7718 (5736 to 9699) | ||
Radiotherapy | NR | 285 (102 to 468) | ||
End-of-life breast cancer care | NR | 277 (−107 to 621) | ||
3 | Surgery | 0 | 0 | |
Systemic therapy | 0.76 | 4004 (1967 to 6312) | ||
Radiotherapy | NR | 106 (0 to 212) | ||
End-of-life breast cancer care | NR | 960 (124 to 1795) | ||
4 | Surgery | 0 | 0 | |
Systemic therapy | 0.70 | 1574 (404 to 2743) | ||
Radiotherapy | 0.01 | 112 (−14 to 237) | ||
End-of-life breast cancer care | NR | 984 (−124 to 2095) | ||
5 | Surgery | 0 | 0 | |
Systemic therapy | 0.70 | 1619 (−76 to 3314) | ||
Radiotherapy | 0 | 0 | ||
End-of-life breast cancer care | NR | 647 (−630 to 1925) | ||
6–40 | Continue year 5 |
Note: CI = confidence interval, NR = not reportable (results for fewer than 10 individuals are not reported).
↵* Score based on genetic testing that predicts 10-year recurrence rate for breast cancer and patient response to chemotherapy.